Sinocare Inc. (SHE:300298)

China · Delayed Price · Currency is CNY

15.91

-0.14 (-0.87%)

Aug 24, 2026, 3:04 PM CST

-24.63% (1Y)

Market Cap	8.48B -27.3%
Revenue (ttm)	4.93B +7.8%
Net Income	133.33M -56.9%
EPS	0.25 -56.2%
Shares Out	533.24M
PE Ratio	64.85
Forward PE	21.45
Dividend	0.22 (1.38%)
Ex-Dividend Date	Jun 13, 2025

Volume	4,370,968
Open	16.04
Previous Close	16.05
Day's Range	15.76 - 16.07
52-Week Range	13.37 - 21.83
Beta	-0.12
Analysts	Buy
Price Target	22.88 (+43.81%)
Earnings Date	Aug 4, 2026

About Sinocare

Sinocare Inc. provides digital diabetes management products in the People’s Republic of China. It offers blood and pressure products, multiparameter testing, and hospital and primary healthcare products; H102 Air, a hemoglobin monitoring system; and Safe AQ UA II, a uric acid monitoring system. The company also exports its products. Sinocare Inc. was founded in 2002 and is based in Changsha, the People’s Republic of China. [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2002

Employees 4,994

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300298

Full Company Profile

Financial Performance

In 2025, Sinocare's revenue was 4.66 billion, an increase of 4.87% compared to the previous year's 4.44 billion. Earnings were 92.65 million, a decrease of -71.61%.

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for 300298 stock is "Buy." The 12-month stock price target is ¥22.88, which is an increase of 43.81% from the latest price.

Price Target

¥22.88

(43.81% upside)

Analyst Consensus: Buy

Stock Forecasts